EULAR recommendations for management of fibromyalgia

Affiliations

¹ Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
² Department of Rheumatology, Cantonal Hospital, Fribourg, Switzerland.
³ ICRCCS Galeazzi Orthopaedic Institute, Milan, Italy.
⁴ Department of Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany.
⁵ Department of Psychosomatic Medicine, Technische Universität München, München, Germany.
⁶ Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
⁷ Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
⁸ Department of Rheumatology, CEDOC-NOVA Medical School, UNL, CHLO, Hospital Egas Moniz, Lisbon, Portugal.
⁹ Department of Physical and Rehabilitation Medicine, Hacettepe University, Division of Internal Medicine, Ankara, Turkey.
¹⁰ Finnish Institute of Occupational Health, Helsinki, Finland.
¹¹ Patient Representative, UK.
¹² Mater Misericordiae University Hospital, Dublin, Ireland.
¹³ Patient Representative, Limassol, Cyprus.
¹⁴ Centre de la Douleur, Hôpital Cochin-Hôtel Dieu, Université Paris Descartes, Paris, France.
¹⁵ Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.

Comment

Gary J Macfarlane et al. Ann Rheum Dis. 2017 Dec.

. 2017 Dec;76(12):e54.

doi: 10.1136/annrheumdis-2017-211587. Epub 2017 May 5.

¹ Epidemiology Group, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
² Department of Rheumatology, Cantonal Hospital, Fribourg, Switzerland.
³ ICRCCS Galeazzi Orthopaedic Institute, Milan, Italy.
⁴ Department of Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany.
⁵ Department of Psychosomatic Medicine, Technische Universität München, München, Germany.
⁶ Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
⁷ Department of Rheumatology, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
⁸ Department of Rheumatology, CEDOC-NOVA Medical School, UNL, CHLO, Hospital Egas Moniz, Lisbon, Portugal.
⁹ Department of Physical and Rehabilitation Medicine, Hacettepe University, Division of Internal Medicine, Ankara, Turkey.
¹⁰ Finnish Institute of Occupational Health, Helsinki, Finland.
¹¹ Patient Representative, UK.
¹² Mater Misericordiae University Hospital, Dublin, Ireland.
¹³ Patient Representative, Limassol, Cyprus.
¹⁴ Centre de la Douleur, Hôpital Cochin-Hôtel Dieu, Université Paris Descartes, Paris, France.
¹⁵ Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.

No abstract available

Keywords: disease activity; patient perspective; treatment.

Conflict of interest statement

Competing interests: None declared.

EULAR revised recommendations for the management of fibromyalgia.
Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. Macfarlane GJ, et al. Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. Epub 2016 Jul 4. Ann Rheum Dis. 2017. PMID: 27377815 Review.
EULAR recommendations underplay importance of severe anxiety and depression in fibromyalgia treatment.
Mercieca C, Borg AA. Mercieca C, et al. Ann Rheum Dis. 2017 Dec;76(12):e53. doi: 10.1136/annrheumdis-2017-211573. Epub 2017 May 5. Ann Rheum Dis. 2017. PMID: 28476878 No abstract available.